Breaking News

Expression Therapeutics Opens Cell and Gene Therapy Manufacturing Facility

The Ohio facility manufactures lentiviral (LV) and adeno associated viral (AAV) vectors.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Expression Therapeutics, a fully integrated clinical stage biotechnology company developing novel cell and gene therapies, opened its state-of-the-art 43,000 square foot cell and viral vector manufacturing facility in Cincinnati, OH.   The company’s manufacturing subsidiary, Expression Manufacturing LLC, provides end-to-end research and development capabilities and early phase and commercial scale manufacturing of both GMP cell and viral vector products. The facility manufactures lentivira...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters